Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
opiods	O
/	O
Coumadin	O
/	O
ACE	O
Inhibitors	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Tachycardia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Mrs.	O
___	O
is	O
a	O
___	O
female	O
with	O
past	O
medical	O
history	O
of	O
atrial	O
fibrillation	O
on	O
dabigatran,	O
essential	O
tremor	O
and	O
asthma,	O
who	O
was	O
seen	O
by	O
her	O
PCP	O
for	O
tachycardia	O
and	O
chest	O
pain	O
in	O
the	O
setting	O
of	O
symptoms	O
and	O
lab	O
tests	O
concerning	O
for	O
hyperthyroidism.	O
The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
___	O
when	O
she	O
noticed	O
increasing	O
fatigue,	O
loss	O
of	O
appetite,	O
watery	O
diarrhea,	O
increasing	O
dyspnea	O
on	O
exertion	O
and	O
decreased	O
exercise	O
tolerance.	O
The	O
symptoms	O
became	O
more	O
sever	O
over	O
the	O
previous	O
several	O
weeks	O
with	O
the	O
patient	O
reporting	O
a	O
10	O
pound	O
weight	B-Weight_loss
loss.	B-Weight_loss
Two	O
weeks	O
ago,	O
she	O
had	O
labs	O
done	O
with	O
her	O
primary	O
care	O
provider	O
that	O
showed	O
TSH	O
less	O
than	O
0.01	O
and	O
a	O
free	O
T4	O
greater	O
than	O
7.7.	O
She	O
presented	O
back	O
to	O
the	O
___	O
office	O
yesterday	O
and	O
was	O
found	O
to	O
be	O
tachycardic	O
with	O
rates	O
reported	O
to	O
be	O
in	O
the	O
130s	O
to	O
140s.	O
She	O
was	O
sent	O
to	O
the	O
ER	O
at	O
___	O
and	O
subsequently	O
to	O
BI	O
with	O
persistent	O
tachycardia	O
for	O
evaluation	O
of	O
thyroid	O
storm.	O
She	O
was	O
afebrile	O
and	O
without	O
mental	B-Delirium
status	B-Delirium
changes.	B-Delirium
In	O
the	O
ED,	O
initial	O
vitals	O
were:	O
98.6	O
130	O
127/92	O
20	O
97%	O
RA.	O
Exam	O
was	O
notable	O
for	O
tachycardia,	O
warm/dry	O
skin.	O
Labs	O
were	O
notable	O
for:	O
TSH	O
<0.01,	O
fT4	O
7.7,	O
ALT	O
225,	O
AST	O
221,	O
INR	O
1.4,	O
Tprot	O
6.3,	O
proBNP	O
2266,	O
Trop-T	O
<0.01,	O
Bicarb	O
21,	O
lactate	O
1.6.	O
Studies	O
were	O
notable	O
for	O
CXR	O
w/	O
no	O
evidence	O
of	O
pulmonary	O
edema.	O
The	O
patient	O
was	O
given	O
Propranolol	O
60mg,	O
NS	O
1000mL,	O
Dabigatran	O
150mg.	O
Endocrinology	O
was	O
consulted.	O
On	O
arrival	O
to	O
the	O
floor,	O
the	O
patient	O
is	O
resting	O
comfortably.	O
She	O
denies	O
any	O
chest	O
pain	O
or	O
palpitations.	O
She	O
is	O
currently	O
taking	O
propranolol	O
for	O
a	O
long	O
history	O
of	O
essential	O
tremor	O
and	O
says	O
her	O
tremor	O
has	O
changed	O
however	O
she	O
has	O
recently	O
noticed	O
a	O
new	O
tremor	O
in	O
her	O
right	O
lower	O
extremity.	O
She	O
reports	O
feeling	O
jittery	O
and	O
slightly	O
anxious.	O
She	O
denies	O
any	O
heat	O
intolerance	O
or	O
sweating.	O
She	O
denies	O
any	O
history	O
of	O
a	O
painful	O
neck,	O
recent	O
or	O
remote	O
sore	O
throat,	O
dysphagia,	O
dysphonia.	O
She	O
says	O
she	O
has	O
a	O
persistent	O
nighttime	O
cough	O
that	O
usually	O
resolves	O
on	O
its	O
own	O
and	O
uses	O
her	O
rescue	O
inhaler	O
___.	O
She	O
reports	O
intermittent	O
abdominal	O
fullness	O
with	O
an	O
occasional	O
increase	O
in	O
urinary	O
frequency.	O
She	O
has	O
not	O
had	O
any	O
iodinated	O
contrast	O
enhanced	O
CT	O
scans.	O
She	O
denies	O
taking	O
any	O
over	O
the-counter	O
or	O
herbal	O
supplements.	O
Notably,	O
she	O
previously	O
received	O
amiodarone	O
for	O
her	O
atrial	O
fibrillation.	O
She	O
received	O
200	O
mg	O
daily	O
dose	O
from	O
___	O
until	O
___.	O
Past	O
Medical	O
History:	O
-	O
ESSENTIAL	O
TREMOR	O
-	O
ATRIAL	O
FIBRILLATION	O
-	O
ASTHMA	O
-	O
STROKE	O
-	O
HYSTERECTOMY	O
-	O
HIP	O
FRACTURE	O
-	O
SKIN	O
CANCERS	O
Social	O
History:	O
___	O
Family	O
History:	O
-	O
No	O
family	O
history	O
of	O
endocrine	O
disease	O
-	O
Brother	O
with	O
asthma	O
-	O
Family	O
history	O
of	O
tremor	O
No	O
h/o	O
seizure.	O
Her	O
parents	O
died	O
of	O
multisystem	O
organ	O
failure	O
at	O
___	O
and	O
___.	O
No	O
clear	O
evidence	O
of	O
MI	O
or	O
stroke.	O
She	O
has	O
4	O
brothers	O
who	O
have	O
all	O
had	O
prostate	O
CA.	O
They	O
are	O
all	O
currently	O
healthy.	O
Physical	O
Exam:	O
ADMISSION	O
PHYISCAL	O
EXAM:	O
=======================	O
VITALS:	O
___	O
1134	O
Temp:	O
97.4	O
PO	O
BP:	O
151/52	O
HR:	O
71	O
RR:	O
18	O
O2	O
sat:	O
98%	O
O2	O
delivery:	O
RA	O
GENERAL:	O
Alert	O
and	O
interactive.	O
In	O
no	O
acute	O
distress.	O
Resting	O
tremor.	O
HEENT:	O
Moderately	O
diffusely	O
enlarged	O
thyroid.	O
Non-tender	O
to	O
palpation.	O
No	O
nodules.	O
No	O
lymphadenopathy.	O
No	O
lid	O
lag	O
or	O
exophthalmos.	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally.	O
No	O
wheezes,	O
rhonchi	O
or	O
rales.	O
No	O
increased	O
work	O
of	O
breathing.	O
ABDOMEN:	O
Non-distended,	O
non-tender	O
to	O
deep	O
palpation.	O
No	O
organomegaly.	O
EXTREMITIES:	O
No	O
pedal	O
edema.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
SKIN:	O
Warm	O
and	O
well-perfused.	O
No	O
rashes.	O
NEUROLOGIC:	O
AOx3.	B-Delirium
CN2-12	O
intact.	O
Moving	O
all	O
4	O
limbs	O
spontaneously.	O
___	O
strength	O
throughout.	O
Normal	O
sensation.	O
Foot	O
clonus	O
R>L.	O
Normal	O
reflexes.	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
=======================	O
___	O
0412	O
Temp:	O
97.4	O
PO	O
BP:	O
129/70	O
R	O
Lying	O
HR:	O
68	O
RR:	O
17	O
O2	O
sat:	O
97%	O
O2	O
delivery:	O
Ra	O
GEN:	O
Alert	O
and	O
interactive.	O
No	O
acute	O
distress.	O
Mild	O
resting	O
tremor	O
unchanged	O
from	O
prior.	O
HEENT:	O
Moderately	O
diffusely	O
enlarged	O
thyroid.	O
Non-tender	O
to	O
palpation.	O
No	O
nodules.	O
No	O
lymphadenopathy.	O
Mild	O
lid	O
lag.	O
COR:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
No	O
murmurs/rubs/gallops.	O
RESP:	O
Clear	O
to	O
auscultation	O
bilaterally.	O
No	O
wheezes,	O
rhonchi	O
or	O
rales.	O
No	O
increased	O
work	O
of	O
breathing.	O
ABD:	O
Non-distended,	O
non-tender	O
to	O
deep	O
palpation.	O
No	O
organomegaly.	O
EXT:	O
Mild	O
pedal	O
edema	O
bilaterally	O
unchanged	O
from	O
prior.	O
Pulses	O
DP/Radial	O
2+	O
bilaterally.	O
SKIN:	O
Warm	O
and	O
well-perfused.	O
No	O
rashes.	O
NEURO:	O
AOx3.	B-Delirium
CN2-12	O
intact.	O
Moving	O
all	O
limbs	O
spontaneously.	O
___	O
strength	O
throughout.	O
Normal	O
sensation.	O
has	O
essential	O
tremor	O
at	O
baseline	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
==============	O
___	O
03:34PM	O
BLOOD	O
WBC-7.0	O
RBC-4.11	O
Hgb-14.1	O
Hct-43.5	O
MCV-106*	O
MCH-34.3*	O
MCHC-32.4	O
RDW-11.9	O
RDWSD-46.5*	O
Plt	O
___	O
___	O
03:34PM	O
BLOOD	O
Neuts-72.7*	O
Lymphs-11.9*	O
Monos-14.7*	O
Eos-0.1*	O
Baso-0.3	O
Im	O
___	O
AbsNeut-5.08	O
AbsLymp-0.83*	O
AbsMono-1.03*	O
AbsEos-0.01*	O
AbsBaso-0.02	O
___	O
03:34PM	O
BLOOD	O
___	O
PTT-40.8*	O
___	O
___	O
03:34PM	O
BLOOD	O
Glucose-97	O
UreaN-15	O
Creat-0.8	O
Na-135	O
K-4.3	O
Cl-100	O
HCO3-21*	O
AnGap-14	O
___	O
09:10AM	O
BLOOD	O
ALT-199*	O
AST-211*	O
LD(LDH)-214	O
AlkPhos-83	O
TotBili-0.8	O
___	O
03:34PM	O
BLOOD	O
cTropnT-<0.01	O
proBNP-2266*	O
___	O
09:10AM	O
BLOOD	O
Albumin-3.5	O
Calcium-9.7	O
Phos-3.3	O
Mg-1.4*	O
___	O
03:34PM	O
BLOOD	O
Cholest-140	O
___	O
12:49PM	O
BLOOD	O
VitB12-1334*	O
Folate-14	O
___	O
03:34PM	O
BLOOD	O
Triglyc-79	O
HDL-61	O
CHOL/HD-2.3	O
LDLcalc-63	O
___	O
06:20AM	O
BLOOD	O
TSH-<0.01*	O
___	O
03:34PM	O
BLOOD	O
T4-33.4*	O
T3-280*	O
calcTBG-<0.20*	O
Free	O
T4->7.7*	O
___	O
03:42PM	O
BLOOD	O
___	O
pO2-46*	O
pCO2-39	O
pH-7.40	O
calTCO2-25	O
Base	O
XS-0	O
Comment-GREEN	O
TOP	O
___	O
03:42PM	O
BLOOD	O
Lactate-1.6	O
___	O
03:42PM	O
BLOOD	O
O2	O
Sat-78	O
OTHER	O
RELEVANT	O
LABS:	O
===================	O
Calculated	O
TBG	O
<0.20.	O
Reference	O
Range	O
0.8-1.3	O
Anti-Thyroglobulin	O
Ab	O
<20.	O
Reference	O
Range	O
___	O
Thyroglobulin	O
201.	O
Reference	O
Range	O
___	O
Thyroid	O
Peroxidase	O
Antibodies	O
<10.	O
Reference	O
range	O
___	O
Thyroid	O
Stimulating	O
Immunoglobulin	O
<89.	O
Reference	O
range	O
<140	O
Iodine,	O
Random	O
___	O
___.	O
Reference	O
range	O
34-523	O
DISCHARGE	O
LABS:	O
===================	O
___	O
06:20AM	O
BLOOD	O
WBC-6.1	O
RBC-3.62*	O
Hgb-12.2	O
Hct-36.9	O
MCV-102*	O
MCH-33.7*	O
MCHC-33.1	O
RDW-11.7	O
RDWSD-44.2	O
Plt	O
___	O
___	O
09:35AM	O
BLOOD	O
___	O
PTT-30.3	O
___	O
___	O
06:20AM	O
BLOOD	O
Glucose-80	O
UreaN-17	O
Creat-1.0	O
Na-137	O
K-4.1	O
Cl-100	O
HCO3-28	O
AnGap-9*	O
___	O
06:20AM	O
BLOOD	O
ALT-204*	O
AST-181*	O
LD(LDH)-181	O
AlkPhos-78	O
TotBili-0.4	O
___	O
02:37AM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.02*	O
___	O
06:20AM	O
BLOOD	O
Albumin-3.0*	O
Calcium-9.7	O
Phos-4.0	O
Mg-1.9	O
___	O
06:20AM	O
BLOOD	O
T4-26.8*	O
T3-168	O
Free	O
T4->7.7*	O
REPORTS:	O
===================	O
___	O
THYROID	O
SCAN	O
W/UPTAKE	O
(IODINE)	O
1.	O
No	O
tracer	O
uptake	O
in	O
the	O
thyroid	O
gland,	O
consistent	O
with	O
subacute	O
thyroiditis.	O
___:	O
THYROID	O
U/S	O
Mild	O
thyromegaly	O
with	O
several	O
subcentimeter	O
nodules.	O
RECOMMENDATION(S):	O
A	O
___	O
thyroid	O
ultrasound	O
is	O
recommended	O
in	O
___	O
years.	O
___	O
TTE	O
LVEF	O
50-55%.	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size,	O
and	O
lownormal	O
regional/global	O
biventricular	O
systolic	O
function.	O
Restrictive	O
filling	O
pattern.	O
Mild	O
tricuspid	O
regurgitation.	O
Mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
___:	O
CXR	O
Comparison	O
to	O
___.	O
In	O
the	O
interval,	O
the	O
patient	O
has	O
developed	O
mild	O
pulmonary	O
edema.	O
Mild	O
enlargement	O
of	O
the	O
cardiac	O
silhouette.	O
Mild	O
elongation	O
of	O
the	O
descending	O
aorta.	O
No	O
no	O
pneumonia,	B-Lower_respiratory_tract_infection
no	O
pneumothorax.	O
ADMISSION	O
EKG:	O
====================	O
___:	O
rate	O
137,	O
narrow	O
complex	O
tachycardia,	O
ectopic	O
atrial	O
tachycardia	O
vs	O
PSVT	O
vs	O
atrial	O
flutter.	O
borderline	O
left	O
axis	O
deviated	O
RELEVANT	O
INTERVAL	O
EKGs:	O
====================	O
___:	O
rate	O
75.	O
sinus	O
rhythm	O
wiht	O
1st	O
degree	O
AV	O
block.	O
left	O
axis	O
deviated	O
___:	O
rate	O
126.	O
atrial	O
fibrillation	O
with	O
rapid	O
ventricular	O
response	O
___:	O
rate	O
111.	O
accelerated	O
junctional	O
rhythm	O
Brief	O
Hospital	O
Course:	O
PATIENT	O
SUMMARY:	O
================	O
___	O
w/	O
Afib	O
on	O
dabigatran,	O
prior	O
exposure	O
to	O
amiodarone,	O
p/w	O
tachycardia,	O
low	O
TSH,	O
elevated	O
fT4,	O
low	O
TSI,	O
elevated	O
urine	O
iodine	O
and	O
negative	O
RAIU	O
c/f	O
subacute	O
thyroiditis	O
secondary	O
to	O
amiodarone	O
c/b	O
atrial	O
fibrillation	O
with	O
HR	O
110s	O
and	O
one	O
episode	O
of	O
atrial	O
tachycardia.	O
At	O
time	O
of	O
discharge,	O
rates	O
were	O
stable	O
in	O
the	O
60-70	O
range.	O
TRANSITIONAL	O
ISSUES:	O
====================	O
[	O
]	O
We	O
recommend	O
that	O
you	O
have	O
outpatient	O
lab	O
work	O
performed	O
on	O
___	O
or	O
___	O
this	O
week.	O
Please	O
obtain:	O
CBC,	O
CMP,	O
TFTs	O
(T3,	O
fT4,	O
TSH),	O
LFTs.	O
Please	O
ask	O
to	O
have	O
a	O
copy	O
of	O
the	O
results	O
faxed	O
to	O
the	O
___	O
clinic	O
at	O
___	O
___,	O
Attn:	O
___	O
[	O
]	O
Please	O
note	O
transanimitis	O
while	O
inpatient,	O
suspected	O
to	O
be	O
due	O
to	O
hyperthyroidism;	O
will	O
need	O
to	O
be	O
trended	O
in	O
outpatient	O
setting.	O
[	O
]	O
Patient	O
had	O
heart	O
rates	O
in	O
60-70	O
range	O
and	O
BPs	O
in	O
the	O
100	O
systolic	O
range	O
at	O
time	O
of	O
discharge.	O
She	O
was	O
maintained	O
on	O
a	O
dosage	O
of	O
propranolol	O
80mg	O
TID	O
at	O
time	O
of	O
discharge,	O
but	O
can	O
likely	O
be	O
weaned	O
to	O
60mg	O
TID	O
in	O
the	O
near	O
future.	O
Please	O
consider	O
dose	O
reduction	O
at	O
PCP	O
___	O
appointment	O
on	O
___.	O
[	O
]	O
Patient	O
had	O
intermittently	O
low	O
magnesium	O
levels	O
while	O
inpatient,	O
and	O
was	O
repleted	O
PRN;	O
please	O
consider	O
rechecking	O
in	O
outpatient	O
setting	O
to	O
ensure	O
normal	O
levels.	O
[	O
]	O
Please	O
follow	O
up	O
with	O
___	O
endocrinology	O
as	O
scheduled	O
below.	O
Will	O
likely	O
need	O
dose	O
reduction	O
in	O
methimazole	O
in	O
near	O
future	O
(discharged	O
on	O
10mg	O
daily).	O
[	O
]	O
Discharged	O
on	O
a	O
high-dose	O
steroid.	O
Started	O
on	O
prophylaxis	O
medications	O
including	O
vitamin	O
D,	O
Pepcid	O
and	O
calcium	O
carbonate.	O
Bactrim	O
was	O
not	O
started,	O
but	O
outpatient	O
provider	O
can	O
consider	O
starting	O
this	O
for	O
PJP	O
prophylaxis.	O
[	O
]	O
Blood	O
pressure	O
was	O
noted	O
to	O
be	O
elevated	O
when	O
initially	O
admitted	O
to	O
the	O
hospital,	O
likely	O
due	O
to	O
hyperthyroidism.	O
Please	O
trend	O
BP	O
in	O
outpatient	O
setting.	O
[	O
]	O
Echocardiogram	O
was	O
performed	O
that	O
showed	O
an	O
ejection	O
fraction	O
of	O
50-55%,	O
evidence	O
of	O
mild	O
TR	O
and	O
Pulmonary	O
Artery	O
Hypertension.	O
Recommend	O
follow	O
up	O
with	O
your	O
PCP	O
to	O
discuss	O
these	O
results	O
further	O
and	O
consider	O
any	O
changes	O
to	O
your	O
current	O
medication	O
regimen.	O
[	O
]	O
___	O
recommended	O
patient	O
for	O
outpatient	O
___,	O
which	O
she	O
had	O
already	O
been	O
engaged	O
in	O
prior	O
to	O
this	O
hospitalization.	O
[	O
]	O
Long-term	O
steroids	O
increase	O
the	O
risk	O
of	O
fracture.	O
We	O
recommend	O
that	O
you	O
follow	O
up	O
with	O
your	O
PCP	O
to	O
schedule	O
an	O
assessment	O
of	O
your	O
bone	O
strength	O
(DEXA	O
scan).	O
ACUTE/ACTIVE	O
ISSUES:	O
====================	O
#	O
Hyperthyroidism	O
/	O
Subacute	O
Thyroiditis	O
Patient	O
p/w	O
clinical	O
and	O
laboratory	O
findings	O
of	O
hyperthyroidism	O
with	O
undetectable	O
TSH	O
and	O
significantly	O
elevated	O
fT4.	O
Did	O
not	O
meet	O
criteria	O
of	O
thyroid	O
storm	O
given	O
lack	O
of	O
hyperpyrexia	O
or	O
acute	O
mental	B-Delirium
status	B-Delirium
changes.	B-Delirium
Confusion	O
noted	O
occasionally	O
in	O
AM.	O
U/S	O
demonstrating	O
mild	O
thyromegaly.	O
Negative	O
RAIU.	O
Thyroglobulin	O
mildly	O
elevated	O
(201),	O
unclear	O
if	O
the	O
elevation	O
represents	O
thyroid	O
destruction.	O
Low	O
TSI,	O
elevated	O
urine	O
iodine	O
consistent	O
with	O
subacute	O
thyroiditis	O
due	O
to	O
amiodarone.	O
Started	O
on	O
methimazole	O
10mg	O
and	O
prednisone	O
20mg	O
(later	O
increased	O
to	O
30mg).	O
Transitioned	O
to	O
PTU	O
200mg	O
TID	O
on	O
___	O
given	O
persistently	O
elevated	O
T3,	O
but	O
then	O
restarted	O
methimazole	O
___	O
on	O
recommendation	O
of	O
endocrinology	O
team.	O
T3	O
decreased	O
to	O
137.	O
HR	O
well-controlled	O
in	O
___	O
with	O
propranolol.	O
#	O
Atrial	O
Fibrillation	O
/	O
Atrial	O
Tachycardia	O
Patient	O
missed	O
one	O
dose	O
of	O
home	O
dabigatran	O
on	O
___	O
___.	O
Patient	O
experienced	O
intermittent	O
atrial	O
fibrillation	O
___	O
with	O
HR	O
110s.	O
Asymptomatic.	O
Likely	O
secondary	O
to	O
hyperthyroidism	O
with	O
possible	O
contribution	O
from	O
volume	O
overload	O
given	O
physical	O
exam.	O
Patient	O
given	O
furosemide	O
20mg	O
IV	O
twice.	O
TTE	O
performed,	O
notable	O
for	O
mildly	O
dilated	O
left	O
atrium.	O
On	O
___,	O
patient	O
experienced	O
an	O
episode	O
of	O
chest	O
discomfort	O
and	O
dizziness.	O
ECG,	O
trops	O
unremarkable.	O
Found	O
to	O
have	O
atrial	O
tachycardia	O
with	O
HR	O
140s.	O
Patient	O
received	O
1500cc	O
NS.	O
Unresponsive	O
to	O
adenosine.	O
Patient	O
and	O
metoprolol	O
10mg	O
and	O
HR	O
subsequently	O
decreased	O
to	O
___.	O
Currently	O
sinus	O
with	O
rate	O
controlled	O
in	O
___	O
with	O
propranolol	O
80	O
TID.	O
#	O
Transaminitis	O
ALT	O
199,	O
AST	O
211,	O
ALP	O
83	O
on	O
admission.	O
Unclear	O
etiology,	O
possibly	O
secondary	O
to	O
hyperthyroidism.	O
Low	O
probability	O
for	O
muscle	O
etiology	O
or	O
primary	O
hepatic	O
etiology.	O
Trended	O
while	O
inpatient.	O
Continued	O
improvement	O
reassuring.	O
Will	O
need	O
ongoing	O
outpatient	O
___.	O
CHRONIC/STABLE	O
ISSUES:	O
======================	O
#	O
Hypertension	O
SBP	O
160-170s	O
on	O
admission	O
likely	O
in	O
setting	O
of	O
hyperthyroidism.	O
SBPs	O
now	O
___	O
controlled	O
with	O
propranolol	O
with	O
possible	O
contribution	O
from	O
methimazole.	O
#	O
CODE:	O
Full	O
(presumed)	O
#	O
CONTACT:	O
___	O
(husband)	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H:PRN	O
Asthma	O
2.	O
Sertraline	O
50	O
mg	O
PO	O
DAILY	O
3.	O
Dabigatran	O
Etexilate	O
150	O
mg	O
PO	O
BID	O
4.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
5.	O
Propranolol	O
20	O
mg	O
PO	O
TID	O
6.	O
beclomethasone	O
dipropionate	O
80	O
mcg/actuation	O
inhalation	O
BID	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Mild/Fever	O
2.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
DAILY	O
3.	O
Famotidine	O
20	O
mg	O
PO	O
Q12H	O
4.	O
MethIMAzole	O
10	O
mg	O
PO	O
DAILY	O
5.	O
PredniSONE	O
30	O
mg	O
PO	O
DAILY	O
Please	O
continue	O
to	O
take	O
this	O
medication	O
until	O
you	O
___	O
with	O
your	O
endocrinologist.	O
6.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
7.	O
Propranolol	O
80	O
mg	O
PO/NG	O
TID	O
Please	O
discuss	O
reducing	O
this	O
dose	O
at	O
your	O
PCP	O
___	O
appointment	O
on	O
___.	O
8.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
___	O
Q6H:PRN	O
Asthma	O
9.	O
beclomethasone	O
dipropionate	O
80	O
mcg/actuation	O
inhalation	O
BID	O
10.	O
Dabigatran	O
Etexilate	O
150	O
mg	O
PO	O
BID	O
11.	O
Montelukast	O
10	O
mg	O
PO	O
DAILY	O
12.	O
Sertraline	O
50	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
==================	O
Hyperthyroidism	O
secondary	O
to	O
amiodarone-induced	O
subacute	O
thyroiditis	O
Atrial	O
Fibrillation	O
Transanimitis	O
Secondary	O
Diagnosis:	O
====================	O
Hypertension	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
======================	O
DISCHARGE	O
INSTRUCTIONS	O
======================	O
Dear	O
___	O
was	O
a	O
privilege	O
caring	O
for	O
you	O
at	O
___.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
were	O
in	O
the	O
hospital	O
because	O
your	O
thyroid	O
was	O
overactive.	O
You	O
were	O
experiencing	O
symptoms	O
including	O
a	O
fast	O
heart	O
rate.	O
WHAT	O
HAPPENED	O
TO	O
ME	O
IN	O
THE	O
HOSPITAL?	O
-	O
In	O
the	O
hospital,	O
we	O
performed	O
several	O
tests	O
to	O
determine	O
the	O
cause	O
of	O
your	O
overactive	O
thyroid.	O
These	O
included	O
several	O
blood	O
tests,	O
an	O
ultrasound	O
of	O
your	O
thyroid,	O
and	O
a	O
radioactive	O
iodine	O
uptake	O
imaging	O
study.	O
The	O
results	O
of	O
these	O
tests	O
were	O
consistent	O
with	O
thyroiditis	O
secondary	O
to	O
your	O
amiodarone	O
medication.	O
Thyroid	O
dysfunction	O
is	O
a	O
rare	O
but	O
known	O
side	O
effect	O
of	O
amiodarone	O
that	O
may	O
appear	O
weeks	O
to	O
months	O
after	O
cessation	O
of	O
the	O
drug.	O
You	O
were	O
treated	O
with	O
a	O
higher	O
dose	O
propranolol	O
to	O
control	O
your	O
heart	O
rate	O
as	O
well	O
as	O
methimazole	O
and	O
prednisone	O
to	O
reduce	O
the	O
activity	O
of	O
your	O
thyroid.	O
WHAT	O
SHOULD	O
I	O
DO	O
AFTER	O
I	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Please	O
continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
and	O
___	O
with	O
your	O
appointments	O
as	O
listed	O
below.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

